Chansoo Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.

Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: May 26, 2026

A multiplex dual-probe RT-LAMP assay for rapid subtype-specific detection of respiratory syncytial virus A and B.

A multiplex dual-probe RT-LAMP assay for rapid subtype-specific detection of respiratory syncytial virus A and B.

Journal: PloS one

Published: May 05, 2026

18F-florastamin positron emission tomography/computed tomography in men with clinical suspicion of prostate cancer: A phase I prospective study.

18F-florastamin positron emission tomography/computed tomography in men with clinical suspicion of prostate cancer: A phase I prospective study.

Journal: Prostate international

Published: April 20, 2025

Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [177Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer.

Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [177Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer.

Journal: Korean journal of radiology

Published: July 14, 2023

A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [177Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial.

A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [177Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial.

Journal: Cancers

Published: November 05, 2022

Mitigation of biofouling with co-deposition of polydopamine and curcumin on the surface of a thin-film composite membrane.

Mitigation of biofouling with co-deposition of polydopamine and curcumin on the surface of a thin-film composite membrane.

Journal: Chemosphere

Published: August 09, 2022

Irreversible electroporation for prostate cancer using PSMA PET-CT.

Irreversible electroporation for prostate cancer using PSMA PET-CT.

Journal: Prostate international

Published: June 19, 2022

A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.

A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.

Journal: Clinical nuclear medicine

Published: May 25, 2021

QCBCT-NET for direct measurement of bone mineral density from quantitative cone-beam CT: a human skull phantom study.

QCBCT-NET for direct measurement of bone mineral density from quantitative cone-beam CT: a human skull phantom study.

Journal: Scientific reports

Published: April 08, 2021

A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.

A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 10, 2020

A pilot study of spiral-wound air gap membrane distillation process and its energy efficiency analysis.

A pilot study of spiral-wound air gap membrane distillation process and its energy efficiency analysis.

Journal: Chemosphere

Published: June 13, 2019

Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial.

Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: May 23, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026